A Study to Test How Well Patients With Plaque Psoriasis Tolerate BI 730357 Over a Longer Period and How Effective it is

NCT03835481 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

165

Enrollment

INDUSTRY

Sponsor class

Stopped Due to company decision.

Conditions

Psoriasis

Interventions

DRUG: BI 730357
DRUG: Placebo to match BI 730357

Sponsor

Boehringer Ingelheim